A major advance in cancer investigation is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This essential cancer protector protein is frequently disabled in many forms of malignancies, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research